Is it okay to just do the component inspection and sampling?
ANRITSU CORPORATION Pharmaceutical Business Div. Infivis Company
Regarding the uniformity of tablets within a lot in the formulation process, GMP regulations require validation. However, current mainstream sampling inspections cannot confirm uniformity for all tablets within a lot. In response, Anritsu has developed the "NIR Tablet Inspection Device." By transmitting NIR (near-infrared) light through the tablets, it enables high-speed inspection of component quantities in a "non-destructive" manner. This allows for inline inspection of all tablets after the tablet press, contributing to the assurance of uniformity of tablet components within the entire lot. Shall we reconsider the quality inspection of tablets once again?
Related Links
You can inquire about downloading materials from the bottom of the linked page.
